RESOURCES

PSG is recognized as the industry’s pre-eminent thought leader producing insightful relevant content to help you address today’s pharmaceutical environment.  Through our cutting-edge client engagements, our experts offer foresight that shape the market.

Blog
Library
Speakers Bureau
Subscriptions
News

Blog

11/16/2022
Oncologists May Prescribe New Neutropenia Agent Over Others in Class, but Therapy Faces Another Challenge

Health Payers
11/16/2022
Biosimilars Are Picking Up Market Share, but Some Uncertainties Still Exist

Health Payers
11/02/2022
A closer look at the complexities of PBM satisfaction

Health Payers

View More |

library

10/01/2019
2019 State of Specialty
Spend and Trend Report

Library
01/30/2019
WHY CONSIDER A PBM PROCUREMENT

Library
12/06/2017
The State of Specialty Management Report

Library

View More |

STAY UP TO DATE WITH RXWIRE, PSG’S WEEKLY PUBLICATION HIGHLIGHTING KEY FDA APPROVALS, CLINICAL RESEARCH, AND TOP INDUSTRY ARTICLES.

SUBSCRIBE TO RXWIRE |

news

09/08/2022
Specialty Trend Rose in 2021, but Biosimilars Are Having Impact

Newsroom
08/29/2022
PSG Announces New Features Designed to Support Biosimilar Strategy

Newsroom
08/23/2022
Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group

Newsroom

View More |